China Pharmaceuticals, Inc. (fka CFMI)

[10 bagger]

CFMI..

Item 5.03 Amendment to Articles of Incorporation or Bylaws.


Effective September 10, 2010, China Pharmaceuticals, Inc. (the “Company”) filed a Certificate of Change to the Articles of Incorporation, which decreases the total number of authorized shares of common stock, par value $.001 per share, from 75,000,000 shares to 25,000,000 and sets forth the terms of a corresponding three-for-one reverse split of the Company’s issued and outstanding common stock. The Company is currently processing the three-for-one reverse split of the Company’s issued and outstanding common stock with the Financial Industry Regulatory Authority and its effectiveness in the marketplace is pending.


The foregoing description of Certificate of Change is a summary and is not complete. Reference is made to the Certificate of Change, which is filed as Exhibit 3.1 to this Form 8-K.


Item 9.01 Financial Statements and Exhibits.


Exhibits

3.1 Certificate of Change to the Articles of Incorporation of China Pharmaceuticals, Inc.